Referred to the House Committee on Energy and Commerce.
The bill adds a new CDC-led cerebral palsy research program within the Public Health Service Act. It directs research on diagnosis, treatment, prevention factors, costs, public health surveillance, education, training, technical assistance, and program evaluation.
Size of federal investment: increase funding vs. keep modest
Relative to its intended legislative type, this bill clearly defines a focused public health research objective and establishes statutory authority and funding to create a CDC-led cerebral palsy research program.
The bill adds a new CDC-led cerebral palsy research program within the Public Health Service Act.
It directs research on diagnosis, treatment, prevention factors, costs, public health surveillance, education, training, technical assistance, and program evaluation.
The bill authorizes $5 million annually for fiscal years 2026–2031 to carry out these activities.
Modest, widely sympathetic public-health measure with small authorization increases prospects; main barrier is obtaining appropriations and floor time in both chambers.
Relative to its intended legislative type, this bill clearly defines a focused public health research objective and establishes statutory authority and funding to create a CDC-led cerebral palsy research program. It provides sufficient high-level mechanisms and an appropriation authorization for a modest program but leaves out several operational details and safeguards commonly expected for research and surveillance programs.
Size of federal investment: increase funding vs. keep modest
These are examples from the analysis, not a ranked list of the most-affected groups.
Size of federal investment: increase funding vs. keep modest
Likely strongly supportive: prioritizes research for a common, lifelong disability and public-health surveillance that can advance equity and care.
Sees potential to reduce lifetime costs and improve services for disabled communities.
Generally supportive but pragmatic: values targeted research and evaluation but wants clear oversight, measurable outcomes, and avoidance of duplication.
Views modest funding as fiscally responsible if well-managed.
Mixed to mildly supportive in principle but cautious: sympathetic to disability research but concerned about federal spending, expansion of CDC responsibilities, and potential program duplication.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Modest, widely sympathetic public-health measure with small authorization increases prospects; main barrier is obtaining appropriations and floor time in both chambers.
The bill has not accumulated any surfaced votes yet.
Size of federal investment: increase funding vs. keep modest
Modest, widely sympathetic public-health measure with small authorization increases prospects; main barrier is obtaining appropriations and…
Relative to its intended legislative type, this bill clearly defines a focused public health research objective and establishes statutory authority and funding to create a CDC-led cerebral palsy research program. It pro…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.